Franklin Biotechnology Discovery Fund

Average Annual Total Returns [further-information] As of 02/29/2020

Month EndAs of 02/29/2020 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) 8.73 4.84 0.78 15.55 11.27
Fund with Sales Charge (%) (POP) 8.73 4.84 0.78 15.55 11.27
NASDAQ Biotechnology Index (%) 1.18 4.88 0.31 15.22 11.33
S&P 500 Index (%) 8.19 9.87 9.23 12.65 7.34
Quarter EndAs of 12/31/2019 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) 35.35 10.96 3.77 16.46 11.54
Fund with Sales Charge (%) (POP) 35.35 10.96 3.77 16.46 11.54
NASDAQ Biotechnology Index (%) 24.41 10.95 3.57 16.34 11.70
S&P 500 Index (%) 31.49 15.28 11.70 13.56 7.81

After-Tax Average Annual Total Returns [further-information] As of 02/29/2020

Month EndAs of 02/29/2020 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold 6.60 3.56 -0.68 14.09
Fund without Sales Charge (%) (NAV) After Shares Sold 6.81 3.58 0.32 12.78
Fund with Sales Charge (%) (POP) Before Shares Sold 6.60 3.56 -0.68 14.09
Fund with Sales Charge (%) (POP) After Shares Sold 6.81 3.58 0.32 12.78
Quarter EndAs of 12/31/2019 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold 32.68 9.60 2.26 14.99
Fund without Sales Charge (%) (NAV) After Shares Sold 22.82 8.34 2.59 13.58
Fund with Sales Charge (%) (POP) Before Shares Sold 32.68 9.60 2.26 14.99
Fund with Sales Charge (%) (POP) After Shares Sold 22.82 8.34 2.59 13.58

Calendar Year Returns

2019 2018 2017 2016 2015 2014 2013
Fund without Sales Charge (%) (NAV) 35.35 -15.41 19.32 -16.82 5.89 34.50 69.49
Fund with Sales Charge (%) (POP) 35.35 -15.41 19.32 -16.82 5.89 34.50 69.49
NASDAQ Biotechnology Index (%) 24.41 -9.32 21.06 -21.68 11.42 34.32 65.97
S&P 500 Index (%) 31.49 -4.38 21.83 11.96 1.38 13.69 32.39

Cumulative Total Returns [further-information] As of 02/29/2020

Month EndAs of 02/29/2020 3 Month YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) -0.47 -3.75 8.73 15.24 3.96 324.47 999.27
Fund with Sales Charge (%) (POP) -0.47 -3.75 8.73 15.24 3.96 324.47 999.27
NASDAQ Biotechnology Index (%) -4.52 -5.32 1.18 15.37 1.57 312.44 1,014.58
S&P 500 Index (%) -5.50 -8.27 8.19 32.62 55.49 229.18 390.65
Quarter EndAs of 12/31/2019 3 Month YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) 27.07 35.35 35.35 36.60 20.33 359.09 1,042.05
Fund with Sales Charge (%) (POP) 27.07 35.35 35.35 36.60 20.33 359.09 1,042.05
NASDAQ Biotechnology Index (%) 21.06 24.41 24.41 36.56 19.17 353.96 1,077.15
S&P 500 Index (%) 9.07 31.49 31.49 53.17 73.86 256.66 434.87

MODERN PORTFOLIO THEORY (MPT) STATISTICSAs of 02/29/2020 (updated monthly)

3 YR 5 YR 10 YR
Standard Deviation (Fund) 22.14 24.75 22.86
Standard Deviation (NASDAQ Biotechnology Index) 20.50 23.14 21.18
Beta 1.04 1.04 1.04
Sharpe Ratio 0.14 -0.01 0.66
Information Ratio -0.01 0.08 0.06
Tracking Error 6.06 5.79 6.02

ADDITIONAL RISK STATISTICSAs of 02/29/2020 (updated monthly)

3 YR 5 YR 10 YR
Beta Bull 1.00 0.95 1.03
Beta Bear 0.92 0.99 1.02
Bull Bear Capture Ratio 1.03 1.07 1.02
% of Positive Months 52.78 55.00 60.83
Gains/Losses 1.27 1.12 1.73
Maximum Drawdown
23.46 37.50 37.50

SALES CHARGE, EXPENSES & FEES As of 09/01/2019 (updated annually)

Gross Expense Ratio 0.72%
Net Expense Ratio [further-information] 0.65%
Max Initial Sales Charge 0.00%
CDSC

Volatility Measures [further-information] As of 02/29/2020 Updated Monthly, based on a 3-year period

Beta 1.04
Sharpe Ratio 0.14
Standard Deviation 22.14

Benchmarks

A benchmark is a comparable broad-based index that can be used to evaluate a fund's performance.

  • NASDAQ Biotechnology Index
  • S&P 500 Index